IL68690A0 - Compounds,compositions and method of treatment for improving circulatory performance - Google Patents

Compounds,compositions and method of treatment for improving circulatory performance

Info

Publication number
IL68690A0
IL68690A0 IL68690A IL6869083A IL68690A0 IL 68690 A0 IL68690 A0 IL 68690A0 IL 68690 A IL68690 A IL 68690A IL 6869083 A IL6869083 A IL 6869083A IL 68690 A0 IL68690 A0 IL 68690A0
Authority
IL
Israel
Prior art keywords
compositions
compounds
treatment
improving circulatory
circulatory performance
Prior art date
Application number
IL68690A
Other languages
English (en)
Original Assignee
Maroko Peter R
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Maroko Peter R filed Critical Maroko Peter R
Publication of IL68690A0 publication Critical patent/IL68690A0/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7028—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages
    • A61K31/7034—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages attached to a carbocyclic compound, e.g. phloridzin
    • A61K31/704—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages attached to a carbocyclic compound, e.g. phloridzin attached to a condensed carbocyclic ring system, e.g. sennosides, thiocolchicosides, escin, daunorubicin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7048—Compounds having saccharide radicals and heterocyclic rings having oxygen as a ring hetero atom, e.g. leucoglucosan, hesperidin, erythromycin, nystatin, digitoxin or digoxin

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Molecular Biology (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
IL68690A 1982-05-14 1983-05-13 Compounds,compositions and method of treatment for improving circulatory performance IL68690A0 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US37812282A 1982-05-14 1982-05-14
US40988382A 1982-08-20 1982-08-20

Publications (1)

Publication Number Publication Date
IL68690A0 true IL68690A0 (en) 1983-09-30

Family

ID=27008080

Family Applications (1)

Application Number Title Priority Date Filing Date
IL68690A IL68690A0 (en) 1982-05-14 1983-05-13 Compounds,compositions and method of treatment for improving circulatory performance

Country Status (11)

Country Link
EP (1) EP0108147B1 (es)
AU (1) AU571184B2 (es)
CA (1) CA1220139A (es)
DE (1) DE3377695D1 (es)
ES (1) ES8703871A1 (es)
GR (1) GR79223B (es)
IE (1) IE55519B1 (es)
IL (1) IL68690A0 (es)
IT (1) IT1173712B (es)
PT (1) PT76690B (es)
WO (1) WO1983003970A1 (es)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR100258849B1 (ko) * 1998-04-24 2000-08-01 박원배 약학적으로 유용한 프로토베르베린염 유도체 및프로토베르베린유도체와 이의 염
CA2467774C (en) 2001-11-14 2011-09-20 Rutgers, The State University Solubilized topoisomerase poisons
CA2467279A1 (en) 2001-11-14 2003-06-26 Edmond J. Lavoie Solubilized topoisomerase poison agents
ATE390923T1 (de) 2001-11-14 2008-04-15 Univ Rutgers Topoisomerase-giftmittel
DE60228484D1 (de) 2001-11-14 2008-10-02 Univ Rutgers Cytotoxische mittel
US6992088B2 (en) 2002-08-09 2006-01-31 Rutgers, The State University Of New Jersey Nitro and amino substituted heterocycles as topoisomerase I targeting agents
US6989387B2 (en) 2002-08-09 2006-01-24 Rutgers, The State University Of New Jersey Nitro and amino substituted topoisomerase agents
US6992089B2 (en) 2002-08-09 2006-01-31 Rutgers, The University Of New Jersey Nitro and amino substituted topoisomerase agents
JP4774212B2 (ja) 2002-11-12 2011-09-14 ラトガーズ、ザ・ステイト・ユニバーシテイ・オブ・ニユー・ジヤージー トポイソメラーゼ−ターゲッティング剤
CN100441183C (zh) * 2005-08-29 2008-12-10 中国医学科学院皮肤病研究所 盐酸13-己基小檗碱和盐酸13-己基巴马汀制备治疗湿疹、皮炎和银屑病的药物用途
WO2010102219A1 (en) 2009-03-06 2010-09-10 Rutgers, The State University Of New Jersey Methylenedioxybenzo [i] phenanthridine derivatives used to treat cancer
EP2405755A4 (en) * 2009-03-11 2012-11-28 Xintria Pharmaceutical Corp Inc METHOD AND COMPOSITIONS FOR TREATING METABOLISM AND CARDIOVASCULAR DISEASES
WO2010127363A1 (en) 2009-05-01 2010-11-04 Rutgers, The State University Of New Jersey Toposiomerase inhibitors
US20140107505A1 (en) * 2012-10-11 2014-04-17 Alon Marmor Determination of ventricular pressure and related values
JP2019515025A (ja) 2016-04-04 2019-06-06 ラトガース ザ ステイト ユニバーシティー オブ ニュージャージー トポイソメラーゼ毒

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL129028C (es) * 1964-02-13
US3420834A (en) * 1964-11-13 1969-01-07 Roussel Uclaf 2,3-dimethoxy-berbines substituted in the 10 position and process
JPS4942700A (es) * 1972-08-25 1974-04-22
US3920665A (en) * 1972-10-19 1975-11-18 Kanebo Ltd Berbine compounds
JPS523397B2 (es) * 1972-11-20 1977-01-27
US3910938A (en) * 1973-01-27 1975-10-07 Kanebo Ltd Berbine derivatives
US4042592A (en) * 1974-05-08 1977-08-16 Kanebo, Ltd. Novel dibenzo[a,g]quinolizinium compounds
US4087426A (en) * 1976-08-16 1978-05-02 Research Corporation Oxybisberberine and a process for its production
SE426548B (sv) * 1978-12-05 1983-01-31 Haessle Ab Fast farmaceutisk beredning innehallande en terapeutiskt effektiv hjertglykosid och en polymer

Also Published As

Publication number Publication date
ES8703871A1 (es) 1987-03-16
PT76690B (en) 1986-03-19
IE55519B1 (en) 1990-10-10
CA1220139A (en) 1987-04-07
EP0108147A1 (en) 1984-05-16
GR79223B (es) 1984-10-22
WO1983003970A1 (en) 1983-11-24
EP0108147A4 (en) 1984-09-13
EP0108147B1 (en) 1988-08-17
AU1706383A (en) 1983-12-02
DE3377695D1 (en) 1988-09-22
ES522754A0 (es) 1987-03-16
IE831098L (en) 1983-11-14
PT76690A (en) 1983-06-01
AU571184B2 (en) 1988-04-14
IT8348294A0 (it) 1983-05-13
IT1173712B (it) 1987-06-24

Similar Documents

Publication Publication Date Title
DE3380762D1 (en) Skin treatment compositions
DE3377263D1 (en) Skin treatment composition
IL68690A0 (en) Compounds,compositions and method of treatment for improving circulatory performance
DE3372843D1 (en) Skin treatment compositions
EP0116538A4 (en) METHOD FOR TREATING PRURITIS AND COMPOSITION THEREOF.
PH17865A (en) Method of treatment
DE3379043D1 (en) Spiro-3-hetero-azolones for treatment of diabetic complications
GB8332450D0 (en) Method of treatment
GB8318991D0 (en) Agent for treatment of wounds
GB8321205D0 (en) Cooling edges of camfollowers during hardening
ZA833421B (en) Compounds,compositions and method of treatment for improving circulatory performance
DE3363428D1 (en) Method of treating flaxen
ZA834402B (en) Skin treatment compositions
ZA83662B (en) Skin treatment composition
DE3368177D1 (en) Water treatment methods and compositions
JPS56168750A (en) Method of treating blood purifier
GB8306271D0 (en) Preservative treatment of timber
GB2122225B (en) After treatment of dyeings afterchroming
DE3369271D1 (en) Treatment of timber
ZA839023B (en) Spiro-3-hetero-azolones for treatment of diabetic complications
PH21490A (en) Method of treating diabetic nephropathy
ZA821567B (en) Method for the treatment of warts
PL236969A1 (en) Method of fit-to-eat treating clamary arms
SU1152591A1 (en) Method of treatment of cramp syndrome
PH22086A (en) Method of treating depression

Legal Events

Date Code Title Description
FF Patent granted
KB Patent renewed